{"brief_title": "Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection", "brief_summary": "This study was designed to provide early access to and evaluate the safety of TPV/r in PI-experienced patients with HIV-1 infection.", "condition": "HIV Infections", "intervention_type": "Drug", "intervention_name": "Ritonavir", "description": "200 mg twice daily", "id": "NCT00097799.xml"}